A nasal insulin spray has shown promising results in treating Alzheimer’s disease.
Scientists from Baptist Medical Center Wake Forest in the US They conducted a study of 60 adults diagnosed with amnestic mild cognitive impairment or mild to moderate Alzheimer’s dementia.
Participants were 20 or 40 international units (IU) of insulin detemir dose, while others received a dose of 20 IU placebo.
The researchers found that those who received the dose of 40 units showed significant improvement in their working memory compared to the group receiving placebo.
In addition, receiving 40 IU of insulin detemir and possessed APOE-e4 – a number associated with an increased risk of Alzheimer’s disease gene – had higher scores on memory tests than the other participants
to investigate whether the treatment had no side effects, the team found that only caused minor adverse reactions.
This article was originally published on barchester, Read the original article here
Posted in: Alzheimer's & Dementia